Dr. Beer on the Immune-Related Adverse Events of Ipilimumab in mCRPC
Автор: OncLive
Загружено: May 16, 2014
Просмотров: 209 views
Tomasz Beer, MD, FACP, professor of medicine, deputy director of the Knight Cancer Institute, Oregon Health and Science University, characterizes the immune-related adverse events associated with ipilimumab in a phase III metastatic castration-resistant prostate cancer trial.

Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: